SPACA1
geneOn this page
Also known as SAMP32
Summary
SPACA1 (sperm acrosome associated 1, HGNC:14967) is a protein-coding gene on chromosome 6q15, encoding Sperm acrosome membrane-associated protein 1 (Q9HBV2). Plays a role in acrosome formation and establishment of normal sperm morphology during spermatogenesis.
The correlation of anti-sperm antibodies with cases of unexplained infertility implicates a role for these antibodies in blocking fertilization. Improved diagnosis and treatment of immunologic infertility, as well as identification of proteins for targeted contraception, are dependent on the identification and characterization of relevant sperm antigens. The protein expressed by this gene is recognized by anti-sperm antibodies from infertile males. Furthermore, antibodies generated against the recombinant protein block in vitro fertilization. This protein localizes to the acrosomal membrane of spermatids and mature spermatozoa where it is thought to play a role in acrosomal morphogenesis and in sperm-egg binding and fusion, respectively.
Source: NCBI Gene 81833 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 55 total — 1 pathogenic
- Phenotypes (HPO): 7
- MANE Select transcript:
NM_030960
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14967 |
| Approved symbol | SPACA1 |
| Name | sperm acrosome associated 1 |
| Location | 6q15 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SAMP32 |
| Ensembl gene | ENSG00000118434 |
| Ensembl biotype | protein_coding |
| OMIM | 612739 |
| Entrez | 81833 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding_CDS_not_defined, 1 protein_coding
ENST00000237201, ENST00000462227, ENST00000462690
RefSeq mRNA: 1 — MANE Select: NM_030960
NM_030960
CCDS: CCDS5014
Canonical transcript exons
ENST00000237201 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000798169 | 88047841 | 88048113 |
| ENSE00000798170 | 88053946 | 88054002 |
| ENSE00000798171 | 88057612 | 88057713 |
| ENSE00000798172 | 88058716 | 88058822 |
| ENSE00000798174 | 88064099 | 88064219 |
| ENSE00003496116 | 88059453 | 88059588 |
| ENSE00003691395 | 88066182 | 88066838 |
Expression profiles
Bgee: expression breadth broad, 31 present calls, max score 92.42.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0886 / max 101.0430, expressed in 4 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 68845 | 0.0799 | 4 |
| 68844 | 0.0086 | 3 |
Top tissues by expression
254 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 92.42 | gold quality |
| right testis | UBERON:0004534 | 92.01 | gold quality |
| testis | UBERON:0000473 | 88.70 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.62 | gold quality |
| sperm | CL:0000019 | 79.87 | silver quality |
| male germ cell | CL:0000015 | 77.39 | silver quality |
| diaphragm | UBERON:0001103 | 72.21 | gold quality |
| buccal mucosa cell | CL:0002336 | 64.00 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 63.10 | gold quality |
| bone marrow cell | CL:0002092 | 61.30 | gold quality |
| endothelial cell | CL:0000115 | 60.93 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 60.25 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 58.38 | gold quality |
| decidua | UBERON:0002450 | 56.55 | gold quality |
| vena cava | UBERON:0004087 | 56.39 | gold quality |
| hair follicle | UBERON:0002073 | 54.07 | gold quality |
| parietal pleura | UBERON:0002400 | 53.69 | gold quality |
| myocardium | UBERON:0002349 | 53.41 | gold quality |
| pleura | UBERON:0000977 | 53.33 | gold quality |
| visceral pleura | UBERON:0002401 | 53.31 | gold quality |
| pancreatic ductal cell | CL:0002079 | 53.10 | silver quality |
| nasal cavity epithelium | UBERON:0005384 | 51.75 | gold quality |
| gingival epithelium | UBERON:0001949 | 50.30 | gold quality |
| ileal mucosa | UBERON:0000331 | 50.11 | silver quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| quadriceps femoris | UBERON:0001377 | 49.22 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| vastus lateralis | UBERON:0001379 | 49.08 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.96 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
59 targeting SPACA1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548D-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548H-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548I | 99.94 | 71.25 | 3481 |
| HSA-MIR-548J-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548O-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548W | 99.94 | 71.24 | 3488 |
| HSA-MIR-548Y | 99.94 | 71.28 | 3514 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-345-3P | 99.89 | 70.23 | 1421 |
| HSA-MIR-577 | 99.78 | 69.13 | 2479 |
Literature-anchored findings (GeneRIF, showing 4)
- SAMP32 was associated with the inner acrosomal membrane and recombinant SAMP32 reacted with serum from an infertile man suggesting that it is isoantigenic (PMID:11870081)
- Human posterior head 20 (hPH20) and homo sapiens sperm acrosome associated 1 (hSPACA1) immunocontraceptive epitopes reduced fertility in male/female mice. (PMID:25209425)
- Spaca1 role in male infertility.Distribution of SPACA1 in the sperm affects the outcomes of conventional in vitro fertilization. (PMID:27185107)
- Bioinformatic prediction of the structure and characteristics of human sperm acrosome membrane-associated protein 1 (hSAMP32) and evaluation of its antifertility function in vivo. (PMID:33220718)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spaca1 | ENSMUSG00000028264 |
| rattus_norvegicus | Spaca1 | ENSRNOG00000008232 |
Protein
Protein identifiers
Sperm acrosome membrane-associated protein 1 — Q9HBV2 (reviewed: Q9HBV2)
Alternative names: Sperm acrosomal membrane-associated protein 32
All UniProt accessions (1): Q9HBV2
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in acrosome formation and establishment of normal sperm morphology during spermatogenesis. Important for male fertility.
Subunit / interactions. Interacts with CYLC1; the interaction may be relevant for proper acrosome attachment to the nuclear envelope. Interacts with CFAP65.
Subcellular location. Cytoplasmic vesicle. Secretory vesicle. Acrosome inner membrane.
Tissue specificity. Testis specific.
Post-translational modifications. N-glycosylated.
Disease relevance. Spermatogenic failure 85 (SPGF85) [MIM:620490] An autosomal recessive male infertility disorder characterized by globozoospermia and reduced progressive sperm motility. The disease may be caused by variants affecting the gene represented in this entry.
RefSeq proteins (1): NP_112222* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR037878 | SPACA1 | Family |
UniProt features (16 total): modified residue 3, compositionally biased region 3, sequence variant 2, topological domain 2, region of interest 2, signal peptide 1, chain 1, glycosylation site 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9HBV2-F1 | 71.63 | 0.39 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 256, 269, 290
Glycosylation sites (1): 31
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 103 (showing top):
chr6q15, GOCC_SECRETORY_GRANULE, GOBP_VESICLE_ORGANIZATION, GOBP_MALE_GAMETE_GENERATION, GOBP_SECRETORY_GRANULE_ORGANIZATION, GOBP_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS, GOBP_ACROSOME_ASSEMBLY, GOBP_ORGANELLE_ASSEMBLY, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, WEBER_METHYLATED_HCP_IN_SPERM_UP, WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN, GOCC_ACROSOMAL_MEMBRANE, GOCC_SECRETORY_VESICLE
GO Biological Process (2): acrosome assembly (GO:0001675), spermatogenesis (GO:0007283)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (5): inner acrosomal membrane (GO:0002079), acrosomal membrane (GO:0002080), acrosomal vesicle (GO:0001669), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 2 |
| spermatid development | 1 |
| cellular component assembly involved in morphogenesis | 1 |
| cellular process involved in reproduction in multicellular organism | 1 |
| secretory granule organization | 1 |
| organelle assembly | 1 |
| male gamete generation | 1 |
| binding | 1 |
| acrosomal membrane | 1 |
| cytoplasmic vesicle membrane | 1 |
| acrosomal vesicle | 1 |
| secretory granule membrane | 1 |
| secretory granule | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
830 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPACA1 | ZPBP | Q9BS86 | 828 |
| SPACA1 | IZUMO1 | Q8IYV9 | 794 |
| SPACA1 | DPY19L2 | Q6NUT2 | 766 |
| SPACA1 | SSMEM1 | Q8WWF3 | 710 |
| SPACA1 | SPACA3 | Q8IXA5 | 702 |
| SPACA1 | SPATA16 | Q9BXB7 | 686 |
| SPACA1 | SPATA46 | Q5T0L3 | 666 |
| SPACA1 | SPESP1 | Q6UW49 | 664 |
| SPACA1 | CCDC62 | Q6P9F0 | 624 |
| SPACA1 | GOPC | Q9HD26 | 589 |
| SPACA1 | TSSK4 | Q6SA08 | 578 |
| SPACA1 | PICK1 | Q9NRD5 | 578 |
| SPACA1 | SPAM1 | P38567 | 571 |
| SPACA1 | SPACA4 | Q8TDM5 | 571 |
| SPACA1 | VPS54 | Q9P1Q0 | 563 |
IntAct
82 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ATP6V0C | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GIMAP5 | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM140 | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLN | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EMP1 | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERTM1 | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMIM3 | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RPRM | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CD72 | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CTXN3 | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NSG1 | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRSN1 | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BNIP3 | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EMP3 | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LSMEM2 | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMAGP | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SGCG | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| THSD7B | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CACNG7 | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPACA1 | AGPAT4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPACA1 | TMEM140 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (188): TUBB3 (Affinity Capture-MS), C14orf2 (Affinity Capture-MS), LMBRD2 (Affinity Capture-MS), RAD51C (Affinity Capture-MS), SLC25A26 (Affinity Capture-MS), GOLIM4 (Affinity Capture-MS), C17orf80 (Affinity Capture-MS), IMPA2 (Affinity Capture-MS), LRFN1 (Affinity Capture-MS), GBF1 (Affinity Capture-MS), HEATR6 (Affinity Capture-MS), TRO (Affinity Capture-MS), GK (Affinity Capture-MS), ARFGEF2 (Affinity Capture-MS), DCP2 (Affinity Capture-MS)
ESM2 similar proteins: A0A2R8Y4Y8, A0A2R8YFL7, A0A2R8YFM6, A0A8J1K1A4, A5D791, E7FKV8, O77726, O88393, P20239, P20783, P26342, P35054, P40200, P47984, Q03167, Q05996, Q08DT3, Q17R60, Q2Q0J1, Q3MHP9, Q3U0X8, Q3V1M1, Q4FZG8, Q4V7E2, Q5BK49, Q5SY80, Q5XI99, Q6DFV8, Q6WRH9, Q6WRI0, Q6X784, Q7TST5, Q80VH0, Q86WS3, Q8JIR8, Q8R1W8, Q925U0, Q95KG7, Q9D9J7, Q9ET62
Diamond homologs: D5K8A9, Q2YDG7, Q9DA48, Q9HBV2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
55 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2577471 | NM_030960.3(SPACA1):c.53G>A (p.Trp18Ter) | Pathogenic |
SpliceAI
1032 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:88048109:GGATG:G | donor_gain | 1.0000 |
| 6:88048110:GATGG:G | donor_gain | 1.0000 |
| 6:88048111:A:T | donor_gain | 1.0000 |
| 6:88053944:A:AG | acceptor_gain | 1.0000 |
| 6:88053944:AGTT:A | acceptor_loss | 1.0000 |
| 6:88053945:G:GG | acceptor_gain | 1.0000 |
| 6:88053945:GT:G | acceptor_gain | 1.0000 |
| 6:88054000:GTG:G | donor_gain | 1.0000 |
| 6:88057710:GGCT:G | donor_gain | 1.0000 |
| 6:88057711:GCTG:G | donor_gain | 1.0000 |
| 6:88059448:A:G | acceptor_gain | 1.0000 |
| 6:88059449:ATAGC:A | acceptor_loss | 1.0000 |
| 6:88059450:TAGC:T | acceptor_loss | 1.0000 |
| 6:88059451:A:AC | acceptor_loss | 1.0000 |
| 6:88059451:A:AG | acceptor_gain | 1.0000 |
| 6:88059452:G:GA | acceptor_gain | 1.0000 |
| 6:88059452:G:GT | acceptor_loss | 1.0000 |
| 6:88059452:GC:G | acceptor_gain | 1.0000 |
| 6:88059452:GCA:G | acceptor_gain | 1.0000 |
| 6:88059452:GCAAT:G | acceptor_gain | 1.0000 |
| 6:88059586:GTG:G | donor_gain | 1.0000 |
| 6:88059586:GTGGT:G | donor_loss | 1.0000 |
| 6:88059587:TGGTA:T | donor_loss | 1.0000 |
| 6:88059589:G:C | donor_loss | 1.0000 |
| 6:88059590:T:A | donor_loss | 1.0000 |
| 6:88059591:AAGT:A | donor_loss | 1.0000 |
| 6:88053945:GTTT:G | acceptor_gain | 0.9900 |
| 6:88053945:GTTTC:G | acceptor_gain | 0.9900 |
| 6:88054001:TGGTA:T | donor_loss | 0.9900 |
| 6:88054003:G:GG | donor_gain | 0.9900 |
AlphaMissense
1923 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:88058801:G:C | W151C | 0.997 |
| 6:88058801:G:T | W151C | 0.997 |
| 6:88058799:T:A | W151R | 0.996 |
| 6:88058799:T:C | W151R | 0.996 |
| 6:88059525:T:A | C183S | 0.995 |
| 6:88059526:G:C | C183S | 0.995 |
| 6:88059567:T:C | F197L | 0.994 |
| 6:88059569:C:A | F197L | 0.994 |
| 6:88059569:C:G | F197L | 0.994 |
| 6:88058787:T:C | F147L | 0.992 |
| 6:88058789:C:A | F147L | 0.992 |
| 6:88058789:C:G | F147L | 0.992 |
| 6:88059555:G:C | A193P | 0.992 |
| 6:88053987:T:A | C84S | 0.991 |
| 6:88053988:G:C | C84S | 0.991 |
| 6:88057647:T:A | C101S | 0.991 |
| 6:88057648:G:C | C101S | 0.991 |
| 6:88059525:T:C | C183R | 0.991 |
| 6:88059527:T:G | C183W | 0.991 |
| 6:88053987:T:C | C84R | 0.990 |
| 6:88057668:T:A | C108S | 0.990 |
| 6:88057669:G:C | C108S | 0.990 |
| 6:88058717:G:C | W123C | 0.990 |
| 6:88058717:G:T | W123C | 0.990 |
| 6:88053989:C:G | C84W | 0.989 |
| 6:88057668:T:C | C108R | 0.989 |
| 6:88057689:T:A | C115S | 0.989 |
| 6:88057690:G:C | C115S | 0.989 |
| 6:88058760:T:C | C138R | 0.989 |
| 6:88058762:T:G | C138W | 0.989 |
dbSNP variants (sampled 300 via entrez): RS1000025312 (6:88052164 C>A,G,T), RS1000089501 (6:88044999 A>G), RS1000297305 (6:88057834 C>A,T), RS1000587066 (6:88045217 A>C), RS1000643946 (6:88062683 G>A), RS1000886381 (6:88056518 A>G,T), RS1001025737 (6:88050664 A>G), RS1001038873 (6:88051004 G>A), RS1001156492 (6:88065846 GA>G), RS1001166233 (6:88052940 CATTAA>C), RS1001277001 (6:88046582 C>T), RS1001310063 (6:88053185 C>G,T), RS1001379269 (6:88066499 C>T), RS1001936224 (6:88059224 A>T), RS1002148037 (6:88065960 A>G)
Disease associations
OMIM: gene MIM:612739 | disease phenotypes: MIM:620490
GenCC curated gene-disease
Mondo (1): spermatogenic failure 85 (MONDO:0957584)
Orphanet (0):
HPO phenotypes
7 total (7 of 7 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0003251 | Male infertility |
| HP:0011462 | Young adult onset |
| HP:0012205 | Globozoospermia |
| HP:0012869 | Acephalic spermatozoa |
| HP:0032560 | Coiled sperm flagella |
| HP:0034011 | Reduced progressive sperm motility |
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000110_8 | Echocardiographic traits | 2.000000e-06 |
| GCST003069_6 | Left superior temporal gyrus thickness (schizophrenia interaction) | 9.000000e-06 |
| GCST012317_6 | Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder | 3.000000e-06 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004295 | left ventricular function |
| EFO:0004298 | cardiovascular measurement |
| EFO:0004530 | triglyceride measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Folic Acid | increases expression | 1 |
| Sodium Selenite | decreases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): spermatogenic failure 85